Should triple-positive breast cancer be recognized as a distinct subtype?
Maria Vittoria Dieci, Valentina Guarneri
Abstract
Human epidermal growth factor receptor-2 (HER2)-positive breast cancer is not a unique entity. The most evident source of heterogeneity within this large breast cancer subtype is determined by the ...
Topics & Concepts
MedicineBreast cancerTriple-negative breast cancerOncologyHuman Epidermal Growth Factor Receptor 2CancerInternal medicineEpidermal growth factor receptorCancer researchHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies